CSPE Best Abstract Award Session
J. Liu,P.-h. Fang,S. Dibs,Y. Hou,X.-f. Li,S. Zhang,H. Tao,J. Zhang,L. Li,Y. Ran,J. Chen,N. Li,L. Feng,R. Hui,J. Pu,M. Bao,T. Tan,S. Yu,K. Chen,C. Huang
DOI: https://doi.org/10.1093/europace/euq491
2011-01-01
Abstract:# High-sensitivity C-reactive protein as a predictor of atrial fibrillation recurrence after primary circumferential pulmonary vein isolation {#article-title-2} Background Atrial fibrillation (AF) recurrence after circumferential pulmonary vein isolation (CPVI) is difficult to predict. Inflammation is associated with the development of AF. Inflammatory markers, such as high-sensitivity C-reactive protein, are related to AF development via atrial remodelling. However, it is unknown whether plasma high-sensitivity C-reactive protein concentration before CPVI can be used as a predictor for AF recurrence. Methods A total of 121 patients without structural heart disease who underwent primary CPVI by a single operator were included in the study (paroxysmal/persistent AF: 77/44). Left atrial diameter was measured by transoesophageal echocardiography. The plasma high-sensitivity C-reactive protein concentration was determined by enzyme-linked immunosorbent assay. Based on the follow-up outcomes, patients were divided into two groups: a recurrence group and a non-recurrence group. Atrial fibrillation recurrence was defined as AF or atrial flutter or atrial tachycardia episodes lasting for ≥30 s during regular follow-up (>12 months). Results A total of 36 (29.8%) patients \[paroxysmal/persistent AF: 19(24.7%)/17(38.6%)] had AF recurrence in mean 23 [range12–44] month follow-up period. The plasma high-sensitivity C-reactive protein concentration in the recurrence group was significantly higher than that in the non-recurrence group for all patients [median (quartile range)\] \[2.22 (1.97) vs. 0.89 (1.30) mg/L, P < 0.001\], for patients with paroxysmal AF [2.12 (2.78) vs. 0.84 (1.15) mg/L, P = 0.028], and for those with persistent AF [2.29 (1.08) vs. 0.89 (1.53) mg/L, P = 0.005). Multiple logistic regression analyses showed that the higher level of the plasma high-sensitivity C-reactive protein ( P < 0.001) was a significant prognostic predictor of AF recurrence, both for patients with paroxysmal AF ( P = 0.012) and those with persistent AF ( P = 0.003). Conclusion Plasma high-sensitivity C-reactive protein concentration before CPVI was associated with AF recurrence after primary CPVI procedure for both paroxysmal and persistent AF patients. Plasma high-sensitivity C-reactive protein concentration could play a role in prediction of AF recurrence after primary CPVI. # Sinus atrial node and atrioventricular node function in atrial fibrillation patients with long interval pause {#article-title-3} Background and objectives Long-interval pause during atrial fibrillation was considered combination with AV node or SA node dysfunction. The AV node and SA node functions of those patients were not determined. The purpose of current study is to investigate the pacemaking function of sinus node and AV conduction of atrial fibrillation (AF) with long-interval pause. Methods Patients with AF and long interval (longer than 3 s) during AF were undergone circumferential pulmonary vein ablation (CPVA), the pacemaking function of sinus node, and AV conduction were studied. Results In 100 atrial fibrillation patients undergone catheter ablation, 14 patients combined long-interval (longer than 3 s) during AF. After CPVA operation was completed, SA node and AV node functions were investigated with program stimulation during sinus rhythm. The minimum atrial pacemaking interval under atropine irrigation was 220–260 ms, the minimum AV conduction time was 250 ms with S1S2 stimulation. The right atrial voltage mapping identified low-voltage (<0.1 mV) regions found only in two patients. No long pause interval occurred during follow-up. Conclusion In AF with long-interval pause, dysfunction of AV node and SA node is less common. # Common RyR2 variants associated with ventricular arrhythmias and sudden cardiac death in chronic heart failure {#article-title-4} Aims Ca2+ cycling plays a critical role in heart failure and lethal arrhythmias. Susceptibility to sudden cardiac death was considered to be a heritable trait in general population. We therefore investigated whether potentially functional variants of RyR2 and L-type calcium-channel genes were related to the risk of ventricular arrhythmias and sudden cardiac death in chronic heart failure in a case–control study. Methods A total of 1244 chronic heart failure patients caused by ischaemic heart disease in 733 (58.9%) patients and dilated cardiomyopathy in 511 (41.1%) patients, and 1032 control subjects were consecutively enrolled in this study. Participants were genotyped using ligase detection reactions for four variants such as rs3766871, rs41315858, and rs790896 in RYR2 and rs723672 (T > C) in CACNA1C. Results We found that the A allele of rs3766871 in RyR2 was associated with an increased risk of ventricular arrhythmias in heart failure patients {odds ratio, 1.66 [95% CI (confidence interval), 1.21–2.26]; P = 0.002}. During a median follow-up period of 32 months in 1058 (85.0%) patients, 296 (28.0%) patients died from heart failure, of whom 141 (47.6%) were sudden cardiac death. After adjustment for age, gender, and suspected risk factors, patients carrying the A allele of rs3766871 had an increased risk for cardiac death {HR (hazard ratio), 1.53 [95% CI, 1.11–2.12]; P = 0.010)} and sudden cardiac death [HR, 1.92 (95% CI, 1.25–2.94); P = 0.003]. Patients carrying the A allele of rs790896 in RyR2 had a reduced risk for sudden cardiac death [HR, 0.65 (95% CI, 0.45–0.92); P = 0.015]. Conclusion The A allele of rs3766871 in RyR2 not only associates with ventricular arrhythmias but also serves as an independent predictor of sudden cardiac death, and the A allele of rs790896 in RyR2 is a protective factor against sudden cardiac death in patients with chronic heart failure. # Role of QT interval dynamicity in predicting sudden death in patients with idiopathic dilated cardiomyopathy {#article-title-5} Aims To investigate the role of QT interval dynamicity in predicting sudden death in patients with idiopathic dilated cardiomyopathy (DCM). Methods The history, physical examination, echocardiography, ECG, and 24h ambulatory electrocardiogram of 55 patients with DCM (DCM group) and 27 healthy people (Control group, Con) were investigated. LVEDD, LVEF, QTd, SDNN, the slope of QT/RR plots of the linear regression, ventricular premature beats (VPB), and non-sustained ventricular tachycardia (NSVT) were determined. Results The LVEDD, QTd, VPB/24h, NSVT/24h, QTe/RR slope and QTp/RR slope were higher in the DCM group, whereas LVEF and SDNN were lower in the DCM group ( P < 0.05). Comparing DCM sudden death and non-sudden death group, LVEF, SDNN, QTp/RR slope, and QTp/RR slope shown significant differences ( P < 0.05). Comparing DCM with NSVT and without NSVT group, LVEF, QTd, VPB/24h, QTp/RR slope, and QTp/RR slope showed significant difference ( P < 0.05). The sudden death rate of DCM patients with QTe/RR slope of ≥0.210 was higher than those having <0.210 (54.5 vs. 21.1%, P < 0.05). Sudden death rate of QTp/RR slope ≥0.190 was higher than those having <0.190 (52.2 vs. 21.9%, P < 0.05). Conclusions QT/RR slope of DCM sudden death group was higher than DCM non-sudden death and Con group significantly. QT/RR slope show high predicting value for sudden death in DCM patients independently or combined with NSVT or LVEF.